SARS CoV-2 seroprevalence in a US school district during COVID-19

被引：1

作者：

Bullis, Sean S. M. ^{[1
]}

Grebber, Benjamin ^{[2
]}

Cook, Sally ^{[3
]}

Graham, Nancy R. ^{[4
]}

Carmolli, Marya ^{[4
]}

Dickson, Dorothy ^{[4
]}

Diehl, Sean A. ^{[4
]}

Kirkpatrick, Beth D. ^{[1
,4
]}

Lee, Benjamin ^{[5
]}

机构：

[1] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA

[2] Univ Vermont, Coll Med, Burlington, VT USA

[3] Vermont Dept Hlth, Burlington, VT 05402 USA

[4] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA

[5] Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA

来源：

BMJ PAEDIATRICS OPEN | 2021年 / 5卷 / 01期

关键词：

COVID-19;

D O I：

10.1136/bmjpo-2021-001259

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Reduced symptomatology and access to testing in children have led to underestimates of paediatric COVID-19 prevalence and raised concerns about school safety. To explore COVID-19 prevalence and risk factors in school settings, we conducted a SARS-CoV-2 serosurvey in a Vermont, USA school district in December 2020. Among 336 students (63%) and 196 teachers/staff (37%), adjusted seroprevalence was 4.7% (95% CI 2.9 to 7.2) and was lowest in preK-5 students (4-10 Years). Seroprevalence was 10-fold higher than corresponding state PCR data but was low overall with no evidence of onward transmissions. These results further support feasibility of in-person learning during COVID-19 with appropriate mitigation measures.

引用

页数：3

共 50 条

[1] ERYTHROCYTES AS A TARGET OF SARS COV-2 IN PATHOGENESIS OF COVID-19
Reva, Ivan
Yamamoto, Tatsuo
Rasskazova, Mariya
Lemeshko, Tatyana
Usov, Victor
Krasnikov, Yuriy
Fisenko, Anna
Kotsyurbiy, Evgeniy
Tudakov, Vladislav
Tsegolnik, Ekaterina
Oleksenko, Olesya
Korobkin, Anatoly
Slabenko, Ellada
Shindina, Anastasiya
Gordzievskaya, Kseniya
Furgal, Anna
Reva, Galina
ARCHIV EUROMEDICA, 2020, 10 (03): : 5 - 11
[2] SARS CoV-2 ( COVID-19) Current Pharmacotherapy for Mother and Infant
Thigpen, Jim
NEONATAL NETWORK, 2021, 40 (03): : 175 - 182
[3] SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020
Gouvea-Reis, Fernando Augusto
Soares da Silva, Danniely Carolinne
Borja, Lairton Souza
Dias, Patricia de Oliveira
Percio, Jadher
Peterka, Cassio
de Oliveira, Janaina
Sodre, Giselle
Feres, Claudia Mendes
Dos Santos, Wallace
Souza, Fabio
Passarella Teixeira, Ana Izabel
Ciliao-Alves, Daiani Cristina
Sierra Romero, Gustavo Adolfo
Noronha, Elza Ferreira
Croda, Julio
Haddad, Rodrigo
Ramalho, Walter Massa
de Moraes, Camile
de Araujo, Wildo Navegantes
INTERNATIONAL JOURNAL OF PRISONER HEALTH, 2023, 19 (02) : 143 - 156
[4] SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
Popova, Anna Y.
Smirnov, Viacheslav S.
Andreeva, Elena E.
Babura, Elena A.
Balakhonov, Sergey V.
Bashketova, Natalia S.
Bugorkova, Svetlana A.
Bulanov, Maxim V.
Valeullina, Natalia. N.
Vetrov, Viacheslav. V.
Goryaev, Dmitriy. V.
Detkovskaya, Tatyana N.
Ezhlova, Elena B.
Zaitseva, Natalia N.
Istorik, Olga A.
Kovalchuk, Irina. V.
Kozlovskikh, Dmitriy N.
Kombarova, Svetlana Y.
Kurganova, Olga. P.
Lomovtsev, Alexander. E.
Lukicheva, Lena A.
Lyalina, Ludmila V.
Melnikova, Albina. A.
Mikailova, Olga M.
Noskov, Alexei K.
Noskova, Ludmila N.
Oglezneva, Elena E.
Osmolovskaya, Tatyana P.
Patyashina, Marina A.
Penkovskaya, Natalia A.
Samoilova, Lada V.
Stepanova, Tatyana F.
Trotsenko, Olga E.
Totolian, Areg A.
VIRUSES-BASEL, 2021, 13 (08):
[5] COVID-19 CAUSED BY THE SARS- CoV-2 AS AN OCCUPATIONAL DISEASE IN POLAND
Swiatkowska, Beata
Rybacki, Marcin
Hanke, Wojciech
MEDYCYNA PRACY-WORKERS HEALTH AND SAFETY, 2023, 74 (06): : 479 - 486
[6] Rate of shed of SARS COV-2 viral RNA from COVID-19 cadavers
Sharma, Meenakshi
Brijwal, Megha
Chakraborty, Nabarun
Choudhary, Aashish
Kumar, Arbind
Srivastav, Sharad
Lalwani, Parin
Agrawal, Richa
Soni, Kapil Dev
Madaan, Nirupam
Malhotra, Rajesh
Mathur, Purva
Lalwani, Sanjeev
Dar, Lalit
Trikha, Anjan
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (12) : 1486 - 1493
[7] COVID-19 and menstrual status: Is menopause an independent risk factor for SARS Cov-2?
Mishra, Neha
Sharma, Ritu
Mishra, Pinky
Singh, Monika
Seth, Shikha
Deori, Trideep
Jain, Payal
JOURNAL OF MID-LIFE HEALTH, 2020, 11 (04) : 240 - 249
[8] The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review
Lazaridis, Dovena
Leung, Simon
Kohler, Lisa
Smith, Carla Hawkins
Kearson, Margaretta L.
Eraikhuemen, Nathaniel
JOURNAL OF PHARMACY PRACTICE, 2022, 35 (06) : 1000 - 1006
[9] SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia
Janha, Ramatoulie E.
Bah, Alasana
Jah, Hawanatu
Touray, Fatima
Idris, Yahaya
Keita, Saikou
Gaye, Yassin
Jallow, Samba
Faye-Joof, Tisbeh
Njie, Baboucarr
Craik, Rachel
Mohammed, Nuredin I.
von Dadelszen, Peter
D'Alessandro, Umberto
Roca, Anna
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 135 : 109 - 117
[10] Safety and Biodistribution of Nanoligomers Targeting the SARS- CoV-2 Genome for the Treatment of COVID-19
McCollum, Colleen R.
Courtney, Colleen M.
O'Connor, Nolan J.
Aunins, Thomas R.
Jordan, Tristan X.
Rogers, Keegan L.
Brindley, Stephen
Brown, Jared M.
Nagpal, Prashant
Chatterjee, Anushree
ACS BIOMATERIALS SCIENCE & ENGINEERING, 2023, 9 (03) : 1656 - 1671

← 1 2 3 4 5 →